Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours (Q37182210)

From Wikidata
Jump to navigation Jump to search
scientific article published on 29 August 2013
edit
Language Label Description Also known as
English
Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours
scientific article published on 29 August 2013

    Statements

    Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours (English)
    29 August 2013
    109
    1414-1419

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit